Flexible Work, Better Balance
Founded in 2001, Title21 is a healthcare software company dedicated to digitizing complex, highly regulated workflows in cell and gene therapy (CGT) and advanced therapies. Its platforms replace manual, paper-based processes with integrated digital solutions spanning manufacturing, quality, compliance, and patient delivery. Since 2022, Title21 is backed by ARCHIMED.
As part of its European expansion, Title21 has acquired MyCellHub, a Belgium-based SaaS company serving biotech and CGT players operating under GMP and GxP constraints. Belgium is now Title21’s European operational hub.
To support this ambition, we are hiring a Vice President Sales Europe & Middle East to own regional commercial growth and build a scalable, high-performing sales organization.
This is a hands-on builder role combining strategy, execution, and leadership in a complex, regulated SaaS environment.
Reporting to the Chief Co...